Table 2.

Relationship between oxidative stress biomarkers and others demographic characteristics of the study population

Outcome		Count	Mean	SD	Median	IQR	P-value
TOS (nmol/mL)
Fever	No	42	29.38	26.76	17	15	0.002
	Yes	36	43.19	27.88	32	55
SpO2	<88	12	73.58	21.50	80.5	12.5	<0.001
	88-90	39	30.51	25.70	20	16
	≥91	27	26.52	19.14	20	17
dur_hospitalisation	=<1 week	55	22.20	13.06	18	13	<0.001
	>1 week	23	70.82	25.10	78	17
Outcome	Alive	57	24.14	17.75	18	13	<0.001
	Dead	21	67.29	26.51	77	53
GSH-C (μmol/ml)
Fever	No	42	188.36	61.84	199.5	91	0.004
	Yes	36	144.56	63.59	124.5	75
SpO2	<88	12	106.25	21.88	99.5	31.5	0.002
	88-90	39	177.79	64.75	189	115
	≥91	27	181.70	66.89	191	110
dur_hospitalisation	=<1 week	55	191.09	60.88	199	101	<0.001
	>1 week	22	108.36	34.48	98.5	34
Outcome	Alive	57	188.12	62.23	199	106	<0.001
	Dead	21	113.90	41.31	101	61
TAC (μmol/dl)
Fever	No	42	361.54	248.19	308	394
	Yes	36	165.19	177.89	55.5	245	<0.001
SpO2	<88	12	227.85	260.14	63.5	347
	88-90	39	243.21	230.49	67	345
	≥91	27	348.58	161.67	318.5	160	0.090
dur_hospitalisation	=<1 week	55	370.43	183.68	308	120
	>1 week	22	213.69	237.32	56	345	0.003
Outcome	Alive	57	377.00	192.11	308	155
	Dead	21	211.44	232.25	59	345	0.002

GSH, glutathione; TAC, total antioxidant capacity; TOS, total oxidant status.